Conference abstract

Prevalence of chronic kidney disease and diabetic dyslipidaemia in a group of diabetics in Cameroon: a cross-sectional study in Buea, South-West of Cameroon

Pan African Medical Journal - Conference Proceedings. 2021:11(12).20 Dec 2021.
doi: 10.11604/pamj-cp.2021.11.12.903

Contact the corresponding author
Keywords: CKD, diabetic dyslipidaemia, diabetes, Cameroon, prevalence
Poster

Prevalence of chronic kidney disease and diabetic dyslipidaemia in a group of diabetics in Cameroon: a cross-sectional study in Buea, South-West of Cameroon

Ibrahim Mbarawa Marat Kofia1,2,3,&, Mohamadou Lawan Loubou1,2,4, Abdel Njounedou1,2, Luc-Aime Kagoue Simeni1,2, Denis Teuwafeu5, Awung Nkeza1,2, Marcellin Ndoe Guiaro6, Denis Zofou7, Guy Kuate Duplex1,2, Dickson Nsagha8, Emmanuel Asongalem1, Djibrilla Kaou3, Jules-Clement Assob Nguedia1,2

1Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon, 2Medical Research and Applied Biochemistry Laboratory, Faculty of Health Sciences, University of Buea, Cameroon, 3Department of Biomedical Sciences, Higher Institute of Sciences Health Techniques and Management of Garoua, Cameroon, 4National Radiation Protection Agency, Yaounde, Cameroon, 5Department of Internal Medicine, Faculty of Health Sciences, University of Buea, Cameroon, 6National Institute of Medical Research and Medicinal Plant study, Yaounde, Cameroon, 7Department of Biochemistry, Faculty of Science, University of Buea, Cameroon, 8Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, Cameroon

&Corresponding author

INTRODUCTION: the prevalence of CKD and diabetic dyslipidemia in Cameroon, Africa or in other parts of the world among diabetics is not clearly estimated but, some studies tried to estimate prevalences in local areas or isolated zones. In addition, assessment of both prevelances of CKD and diabetic dyslipidaemia are not well documented. The present study aimed to estimate the prevalence of CKD and diabetic dyslipidaemia among diabetics. METHODS: this was a cross-section study conducted during 5 months in Buea, Cameroon. Independent t-test and Chi-square test were used to compare means and variance between groups and P < 0.05was considered significant. RESULTS: one hundred and twenty (120) diabetics enrolled. Sixty three point thirty three percent (63.33%) were females, 53.33% hypertensive, 74.16% overweight and obese and 32.50% presented real obesity. The mean of eGFR was 92.76 ml/min/1.73m2 and, woman presented the lower value (89.55±43.49ml/min/1.73m2) compared to men (98.37±87.43 ml/min/1.73m2) (X2 = 0.107; P = 0.466). The prevalence of CKD was 70.83% and the stage 2 was the high prevalent (36.60%). 20.83% presented CKD from stage 3 to 5. The prevalence of micro-albuminuria was 30% and macro-albuminuria was prevalent at 3.33%. Diabetic dyslipidaemia affected about half of the study population with a prevalence of 48.9%. The co-affection micro-albuminuria and diabetic dyslipidaemia was prevalent at 16.66%, against 2.50% for the co-affection macro-albuminuria and diabetic dyslipidaemia. The prevalence of diabetic dyslipidaemia among diabetic with CKD was 39.16% (X2 = 0.118). CONCLUSION: this study shown the high prevalence of CKD in diabetics and, was the first to assess the prevalence of both CKD and diabetic dyslipidaemia in diabetic Cameroonians.